John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$230M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$207M |
| 3 |
EA
Electronic Arts
EA
|
+$205M |
| 4 |
Starbucks
SBUX
|
+$171M |
| 5 |
Baidu
BIDU
|
+$159M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$185M |
| 2 |
Elevance Health
ELV
|
+$180M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$169M |
| 4 |
Walt Disney
DIS
|
+$168M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$166M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.51% |
| 2 | Technology | 14.81% |
| 3 | Industrials | 12.21% |
| 4 | Healthcare | 10.11% |
| 5 | Financials | 6.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
AngloGold Ashanti
AU
$60.9B
| $1.72M | 0.01% |
137,005
+55,690
| +68% | +$571K |
|
1327
Simpson Manufacturing
SSD
$7.69B
| $1.72M | 0.01% |
31,721
+2,243
| +8% | +$132K |
|
1328
Rigel Pharmaceuticals
RIGL
$843M
| $1.71M | 0.01% |
74,503
+13,210
| +22% | +$373K |
|
1329
PUT
Marvell Technology
MRVL
$206B
| $1.71M | 0.01% |
105,800
+93,700
| +774% | +$1.55M |
|
|
ALEX
1330
DELISTED
Alexander & Baldwin
ALEX
| $1.7M | 0.01% |
92,532
+70,969
| +329% | +$1.43M |
|
1331
CALL
VanEck Junior Gold Miners ETF
GDXJ
$9.83B
| $1.69M | 0.01% |
55,900
+17,100
| +44% | +$481K |
|
1332
CALL
FirstEnergy
FE
$26.9B
| $1.69M | 0.01% |
44,900
-10,800
| -19% | -$409K |
|
1333
CALL
CSX Corp
CSX
$95.3B
| $1.68M | 0.01% |
81,300
+56,400
| +227% | +$1.3M |
|
1334
PUT
AutoZone
AZO
$49.1B
| $1.68M | 0.01% |
2,000
-1,000
| -33% | -$802K |
|
|
DMC
1335
Del Monte Corp
DMC
$1.51B
| $1.68M | 0.01% |
59,299
+46,087
| +349% | +$1.44M |
|
|
ATRS
1336
DELISTED
Antares Pharma, Inc.
ATRS
| $1.67M | 0.01% |
615,462
+352,830
| +134% | +$1.16M |
|
|
TRVG
1337
trivago
TRVG
$394M
| $1.67M | 0.01% |
+59,391
| New | +$1.77M |
|
1338
iShares 20+ Year Treasury Bond ETF
TLT
$46.6B
| $1.67M | 0.01% |
+13,747
| New | +$1.59M |
|
|
IBKC
1339
DELISTED
IBERIABANK Corp
IBKC
| $1.67M | 0.01% |
25,949
-10,132
| -28% | -$744K |
|
1340
Charter Communications
CHTR
$17.9B
| $1.67M | 0.01% |
+5,850
| New | +$1.83M |
|
|
EPZM
1341
DELISTED
Epizyme, Inc
EPZM
| $1.67M | 0.01% |
270,213
+228,192
| +543% | +$1.74M |
|
|
MCRN
1342
DELISTED
Milacron Holdings Corp.
MCRN
| $1.67M | 0.01% |
140,030
+103,534
| +284% | +$1.56M |
|
|
ZIXI
1343
DELISTED
Zix Corporation
ZIXI
| $1.66M | 0.01% |
289,168
+55,755
| +24% | +$332K |
|
1344
Magnite
MGNI
$3.38B
| $1.66M | 0.01% |
443,736
+88,410
| +25% | +$338K |
|
|
CERN
1345
DELISTED
Cerner Corp
CERN
| $1.66M | 0.01% |
31,555
-462,879
| -94% | -$26.8M |
|
1346
PUT
Twilio
TWLO
$34.2B
| $1.64M | 0.01% |
18,400
-900
| -5% | -$73.1K |
|
1347
Avient
AVNT
$4.07B
| $1.63M | 0.01% |
+56,896
| New | +$1.9M |
|
|
PGNX
1348
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $1.62M | 0.01% |
+386,179
| New | +$1.97M |
|
|
GAP
1349
PUT
The Gap Inc
GAP
$7.33B
| $1.62M | 0.01% |
62,900
+35,300
| +128% | +$943K |
|
|
PNNT
1350
Pennant Park Investment Corp
PNNT
$246M
| $1.62M | 0.01% |
253,676
-164,565
| -39% | -$1.17M |
|
Similar funds
John Overdeck's Q4 2018 Portfolio in Review
As of Q4 2018, John Overdeck held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
John Overdeck withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.
Against the trend, John Overdeck opened a new position in Starbucks worth $176M.
- John Overdeck's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
- John Overdeck added most to SLB Ltd in Q4 2018, an estimated $230M increase.
- John Overdeck's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
- John Overdeck fully exited Elevance Health in Q4 2018, selling an estimated $180M.
- John Overdeck's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
- John Overdeck opened 729 new positions and closed 943 in Q4 2018.
- John Overdeck's portfolio value fell 30% quarter-over-quarter to $25.5B.
Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.